Role of the adventitia in the cyclic GMP-mediated relaxant effect of N ω-hydroxy-L-arginine in rat aorta

Journal of Vascular Research

Volumn 42, Issue 4, 2005, Pages 331-336

  Beranova, Petra ^a   Schott, Christa ^a   Chalupsky, Karel ^a   Kleschyov, Andrei L ^a   Stoclet, Jean Claude ^a   Muller, Bernard ^a,b  

^a CNRS   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Adventitia; Cyclic GMP; N hydroxy L arginine; Nitric oxide; Rat aorta; Vasorelaxation

Indexed keywords

ARGININE DERIVATIVE; CYCLIC GMP; FORSKOLIN; N ACETYL S NITROSOPENICILLAMINE; N OMEGA HYDROXY LEVO ARGININE; NITRIC ACID DERIVATIVE; NITRIC OXIDE; NORADRENALIN; UNCLASSIFIED DRUG;

ADVENTITIA; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENDOTHELIUM; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ANIMALS; AORTA; ARGININE; CONNECTIVE TISSUE; CYCLIC GMP; MALE; NOREPINEPHRINE; RATS; RATS, WISTAR; VASOCONSTRICTION; VASODILATION;

EID: 23844523571     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086489     Document Type: Article

References (23)

1. Stuehr DJ: Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol 1997;37:339-359.
2. ω-hydroxy-L-arginine in rats treated with bacterial lipopolysaccharide. Eur J Pharmacol 1995;275:R1-R3.
3. ω-hydroxy-L-arginine in patients with rheumatoid arthritis and systemic lupus erythematosus as an index of an increased nitric oxide synthase activity. Ann Rheum Dis 1997;56:330-332.
4. Garlichs CD, Beyer J, Zhang H, Schmeisser A, Plotze K, Mugge A, Schellong S, Daniel WG: Decreased plasma concentrations of Nω-hydroxy-L-arginine as a marker of reduced NO formation in patients with combined cardiovascular risk factors. J Lab Clin Med 2000;135:419-425.
5. ω-hydroxy-L-arginine: a novel arginine analog capable of causing vasorelaxation in bovine intrapulmonary artery. Biochem Biophys Res Commun 1991;176:528-534.
6. Abdul-Hussain MN, Jia YL, Hussain SNA: Mechanisms mediating the vasodilatory effects of Nω-hydroxy-L-arginine in coronary arteries. Eur J Pharmacol 1996;305:155-161.
7. Vetrovsky P, Boucher JL, Schott C, Beranova P, Chalupsky K, Callizot N, Muller B, Entlicher G, Mansuy D, Stoclet JC: Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta. J Pharmacol Exp Ther 2002;303:823-830.
8. Gonzalez MC, Arribas SM, Molero F, Fernandez-Alfonso MS: Effect of removal of adventitia on vascular smooth muscle contraction and relaxation. Am J Physiol Heart Circ Physiol 2001;280:H2876-H2881.
9. Gutterman DD: Adventitia-dependent influences on vascular function. Am J Physiol 1999;277:H1265-H1272.
10. Tsutsui M, Onoue H, Iida Y, Smith L, O'Brien T, Katusic ZS: Adventitia-dependent relaxations of canine basilar arteries transduced with recombinant eNOS gene. Am J Physiol 1999;276:H1846-H1852.
11. Kleschyov AL, Muller B, Schott C, Stoclet JC: Role of adventitial nitric oxide in vascular hyporeactivity induced by lipopolysaccharide in rat aorta. Br J Pharmacol 1998;124:623-626.
12. Kleschyov AL, Muller B, Keravis T, Stoeckel ME, Stoclet JC: Adventitia-derived nitric oxide in rat aortas exposed to endotoxin: cell origin and functional consequences. Am J Physiol Heart Circ Physiol 2000;279:H2743-H2751.
13. Rey FE, Pagano PJ: The reactive adventitia: fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol 2002;22:1962-1971.
14. Chalupsky K, Lobysheva I, Nepveu F, Gadea I, Beranova P, Entlicher G, Stoclet JC, Muller B: Relaxant effect of oxime derivatives in isolated rat aorta: role of nitric oxide (NO) formation in smooth muscle. Biochem Pharmacol 2004;67:1203-1214.
15. Martin W, Villani GM, Jothianandan D, Furchgott RF: Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by certain ferrous hemoproteins. J Pharmacol Exp Ther 1985;233:679-685.
16. ω-hydroxy-L-arginine homologues and hydroxylamine as nitric oxide-dependent vasorelaxant agents. Eur J Pharmacol, in press.
17. Kleschyov AL, Oelze M, Daiber A, Huang Y, Mollnau H, Schulz E, Sydow K, Fichtischerer B, Mulsch A, Munzel T: Does nitric oxide mediate the vasodilator activity of nitroglycerin? Circ Res 2003;93:e104-e112.
18. Chen AFY, Jiang SW, Croty TB, Tsutsui M, Smith LA, O'Brien T, Katusic ZS: Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries. Proc Natl Acad Sci USA 1997;94:12568-12573.
19. De Meyer GR, Kockx MM, Cromheeke KM, Seye CI, Herman AG, Bult H: Periadventitial inducible nitric oxide synthase expression and intimal thickening. Arterioscler Thromb Vasc Biol 2000;20:1896-1902.
20. Hecker M, Boese M, Schini-Kerth VB, Mulsch A, Busse R: Characterization of the stable L-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an NG-hydroxyl-L-arginine- nitric oxide adduct. Proc Natl Acad Sci USA 1995;92:4671-4675.
21. Williams JK, Armstrong ML, Heistad DD: Vasa vasorum in atherosclerotic coronary arteries: responses to vasoactive stimuli and regression of atherosclerosis. Circ Res 1988;62:515-523.
22. Heistad DD, Armstrong ML, Marcus ML: Hyperemia of the aortic wall in atherosclerotic monkeys. Circ Res 1981;48:669-675.
23. Kockx MM, Cromheeke KM, Knaapen MW, Bosmans JM, De Meyer GR, Herman AG, Bult H: Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 2003;23:440-446.